日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Boesenbergia rotunda–Derived Phytochemicals as Potent Inhibitors of SARS‐CoV‐2 Papain–Like Protease (PLpro): Insights From Molecular Docking and Dynamic Simulation

姜黄(Boesenbergia rotunda)来源的植物化学物质作为SARS-CoV-2木瓜蛋白酶样蛋白酶(PLpro)的有效抑制剂:来自分子对接和动态模拟的启示

Ghimenti, Federico; Berthier, Ludovic; Kurchan, Jorge; van Wijland, Frédéric; Smith, Conor M; Hambly, Roisin; Gatault, Solene; Iglesias-Martinez, Luis F; Kearns, Sean; Rea, Helen; Lynam-Loane, Kate; Kirthi, Shivashini; Hughes, Rosalind; Kolch, Walter; Fletcher, Jean M; Kirby, Brian; Shen, Kexin; Jiang, Shiyu; Gui, Ailing; Yan, Yichen; Sun, Hui; Wang, Jiachen; Yu, Baohua; Liu, Yizhen; Zhang, Qunling; Khan, Dhrubo Ahmed; Sheikh, Mohammad Ashik; Imon, Raihan Rahman; Imtiaz, Md; Ahmed, Shamin; Gharami, Harasit; Labana, Ryan V; Jimoh, Tajudeen O; Gaurav, Anand; Pereira, Maria L; Nawaz, Muhammad; Dungca, Julieta Z; Hasan, Md Nazmul; Ghosh, Manik; Nissapatorn, Veeranoot

Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

来那度胺联合R-CHOP方案(R2-CHOP)治疗新诊断的双表达弥漫性大B细胞淋巴瘤:一项前瞻性II期临床试验

Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Liu, Xiaojian; Ji, Dongmei; Xia, Zuguang; Jin, Jia; Tao, Rong; Zhang, Wenhao; Li, Xiaoqiu; Zhang, Shengjian; Wang, Zezhou; Wang, Jiachen; Hong, Xiaonan; Cao, Junning

USP1-TRAF2 axis-regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma

USP1-TRAF2轴调控的mortalin稳定性通过破坏外周T细胞淋巴瘤中的钙转运介导化疗耐药性

Gui, Ailing; Yan, Yichen; Jiang, Shiyu; Chen, Feng; Zhou, Xiaolong; Sun, Qi; Qiu, Shi; Wu, Jichuan; Li, Xiya; Zhang, Junyi; Liu, Jie; Zhu, Shun; Wang, Lan; Liu, Wen; Zuo, Ji; Zhang, Qunling; Yang, Ling

Selinexor combined with R-GDP as salvage therapy in relapsed/refractory diffuse large B-cell lymphoma

Selinexor联合R-GDP作为复发/难治性弥漫性大B细胞淋巴瘤的挽救治疗

Jiang, Shiyu; Li, Youli; Liu, Chuanxu; Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Zhang, Wenhao

Genomic risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma

弥漫性大B细胞淋巴瘤患者中枢神经系统复发的基因组风险因素

Jiang, Shiyu; Zhang, Qunling; Jin, Jia; Zhang, Wenhao

Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL

弥漫性大B细胞淋巴瘤中通过二代测序检测到的MYC、BCL2和BCL6重排的特征和临床价值

Zeng, Yupeng; Wei, Ran; Bao, Longlong; Xue, Tian; Qin, Yulan; Ren, Min; Bai, Qianming; Yao, Qianlan; Yu, Chengli; Chen, Chen; Wei, Ping; Yu, Baohua; Cao, Junning; Li, Xiaoqiu; Zhang, Qunling; Zhou, Xiaoyan

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study

西达米德联合R-GDP治疗不适合自体移植的复发/难治性弥漫性大B细胞淋巴瘤患者:一项前瞻性、单臂、II期研究

Chen, Guang-Liang; Xue, Kai; Zhang, Qunling; Xia, Zu-Guang; Jin, Jia; Li, Ran; Liu, Yizhen; Lv, Fangfang; Hong, Xiaonan; Li, Xiaoqiu; Cao, Junning

PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis

PD-1抑制剂联合化疗治疗难治性EBV阳性弥漫性大B细胞淋巴瘤:一项回顾性分析

Li, Youli; Wu, Yonghe; Cao, Sufen; Yu, Baohua; Zhang, Qunling; Xia, Zuguang; Cao, Junning; Lv, Fangfang; Chen, Guang-Liang

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

四个疗程的 R-CHOP 方案化疗后,根据中期 PET/CT 检查结果阴性,进行两次利妥昔单抗治疗:一项前瞻性试验的分析

Jin, Jia; Ji, Dongmei; Xia, Zuguang; Xue, Kai; Zhang, Qunling; Liu, Yizhen; Cao, Junning; Hong, Xiaonan; Gu, Juan J; Guo, Ye; Lv, Fangfang

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma

原发性乳腺弥漫性大B细胞淋巴瘤的临床特征和预后因素

Chen, Guang-Liang; Li, Doudou; Cao, Sufen; Jiang, Shiyu; Zhang, Qunling; Jin, Jia; Xia, Zuguang; Liu, Yizhen; Liu, Xiaojian; Zhu, Yanzhe; Chen, Yu; Gu, Lingli; Hong, Xiaonan; Cao, Junning; Tao, Rong; Lv, Fangfang